General

Showing 1505–1520 of 2282 results

Article: P1.01 Development of a CLL-MRD staining protocol without the use of tandem dyes, and comparison with the ERIC 6-Color Protocol
€3.03 Add to cart
Article: P1.01 Flow cytometric screening in patients at risk for paroxysmal nocturnal hemoglobinuria and evaluation of clone sizes: a retrospective study
€3.03 Add to cart
Article: P1.01 Myeloid Derived Suppressor Cells induce Multiple Myeloma cell survival through AMPK activation
€3.03 Add to cart
Article: P1.02 Acquired hemophilia: a retrospective evaluation in the Ghent University Hospital
€3.03 Add to cart
Article: P1.02 Hypercalcemia and osteolytic bone lesions in adult B-cell lymphoblastic leukemia: a rare but potentially life-threatening presentation
€3.03 Add to cart
Article: P1.02 In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma
€3.03 Add to cart
Article: P1.03 Abnormal IGF-binding protein profile in the bone marrow of multiple myeloma patients
€3.03 Add to cart
Article: P1.03 Comparison of hemoglobin on RapidPoint 500 blood gas analyser (Siemens) to XE-5000 cell counter (Sysmex)
€3.03 Add to cart
Article: P1.03 Thymoquinone induces DNA damage, apoptosis and inhibits proliferation in germinal center subtype of diffuse large B-cell lymphoma
€3.03 Add to cart
Article: P1.04 Multiple myeloma cells instruct myeloid-derived suppressor cells to release pro-angiogenic cytokines
€3.03 Add to cart
Article: P1.04 Tumor-associated macrophages induce Multiple Myeloma cell survival and STAT3 activation
€3.03 Add to cart
Article: P1.05 A multicentre study characterising different regimens for introducing second- or third-line anagrelide in 177 patients in France
€3.03 Add to cart
Article: P1.05 Exosomal miR-146a from multiple myeloma cells regulates cytokine and chemokine secretion in mesenchymal stromal cells
€3.03 Add to cart
Article: P1.06 An unusual presentation of tuberculosis
€3.03 Add to cart
Article: P1.06 Bilateral Bell’s palsy leading to the diagnosis of chronic lymphocytic leukemia
€3.03 Add to cart
Article: P1.06 Distinguishing leukemic B-lymphoblasts from normal B-cell precursors using cut-off values for expression of CD24, CD38, CD58 and CD66c
€3.03 Add to cart

Article: P1.01 Development of a CLL-MRD staining protocol without the use of tandem dyes, and comparison with the ERIC 6-Color Protocol

Article: P1.01 Flow cytometric screening in patients at risk for paroxysmal nocturnal hemoglobinuria and evaluation of clone sizes: a retrospective study

Article: P1.01 Myeloid Derived Suppressor Cells induce Multiple Myeloma cell survival through AMPK activation

Article: P1.02 Acquired hemophilia: a retrospective evaluation in the Ghent University Hospital

Article: P1.02 Hypercalcemia and osteolytic bone lesions in adult B-cell lymphoblastic leukemia: a rare but potentially life-threatening presentation

Article: P1.02 In vivo treatment with epigenetic modulating agents induces transcriptional alterations associated with prognosis and immunomodulation in multiple myeloma

Article: P1.03 Abnormal IGF-binding protein profile in the bone marrow of multiple myeloma patients

Article: P1.03 Comparison of hemoglobin on RapidPoint 500 blood gas analyser (Siemens) to XE-5000 cell counter (Sysmex)

Article: P1.03 Thymoquinone induces DNA damage, apoptosis and inhibits proliferation in germinal center subtype of diffuse large B-cell lymphoma

Article: P1.04 Multiple myeloma cells instruct myeloid-derived suppressor cells to release pro-angiogenic cytokines

Article: P1.04 Tumor-associated macrophages induce Multiple Myeloma cell survival and STAT3 activation

Article: P1.05 A multicentre study characterising different regimens for introducing second- or third-line anagrelide in 177 patients in France

Article: P1.05 Exosomal miR-146a from multiple myeloma cells regulates cytokine and chemokine secretion in mesenchymal stromal cells

Article: P1.06 An unusual presentation of tuberculosis

Article: P1.06 Bilateral Bell’s palsy leading to the diagnosis of chronic lymphocytic leukemia

Article: P1.06 Distinguishing leukemic B-lymphoblasts from normal B-cell precursors using cut-off values for expression of CD24, CD38, CD58 and CD66c